Bristol Medicaid subpoena
Executive Summary
Bristol-Myers Squibb "best price" reporting requirements under Medicaid are the subject of a subpoena from Massachusetts U.S. Attorney's Office, company says in Securities & Exchange Commission filing Aug. 8. Bristol recently commenced an "internal review" to determine whether Medicaid rebates and pricing practices have been appropriate (1"The Pink Sheet" July 28, 2003, p. 33). Bristol met with Boston U.S. Attorney's Office to "discuss the review and its plan for sharing the results of the review," filing says. The company "subsequently received a subpoena...relating to the subject matter of the review"...